Stabilized copolymers of ethylene with ethylenically unsaturated
carboxylic acids
    2.
    发明授权
    Stabilized copolymers of ethylene with ethylenically unsaturated carboxylic acids 失效
    乙烯与烯属不饱和羧酸的稳定共聚物

    公开(公告)号:US5276135A

    公开(公告)日:1994-01-04

    申请号:US3819

    申请日:1993-01-11

    申请人: Richard J. Powell

    发明人: Richard J. Powell

    CPC分类号: C08F6/26 C08K3/20

    摘要: The viscosity stability of a copolymer of ethylene with at least one comonomer which is an ethylenically unsaturated carboxylic acid is improved by exposing the isolated copolymer to moisture for a sufficient period to cause the copolymer to retain at least 20 weight percent more water than it would retain if it were purged with air or nitrogen heated to a temperature at least 5.degree. C. above ambient, which air or nitrogen has not been humidified after it has been heated to such temperature.

    摘要翻译: 乙烯与至少一种作为烯键式不饱和羧酸的共聚单体的共聚物的粘度稳定性通过将分离的共聚物暴露于水分足够长的时间来改善,使共聚物保留比保留的水多至少20重量% 如果用空气或氮气吹扫,加热到高于环境温度至少5摄氏度的温度,哪些空气或氮气在加热到这样的温度之后没有被加湿。

    Flexible, low haze chlorine-free ethylene copolymer article
    3.
    发明授权
    Flexible, low haze chlorine-free ethylene copolymer article 失效
    柔性低雾无氯乙烯共聚物制品

    公开(公告)号:US5399401A

    公开(公告)日:1995-03-21

    申请号:US200809

    申请日:1994-02-22

    申请人: Richard J. Powell

    发明人: Richard J. Powell

    摘要: Highly flexible articles having wall thickness of at least 0.01 inches are made from chlorine-free direct ethylene copolymers containing small amounts of selected known slip additives. Articles in the form of tubes or tubing have particular utility for replacement of PVC based tubing used in medical applications.

    摘要翻译: 具有至少0.01英寸的壁厚度的高度柔性制品由含有少量选定的已知滑动添加剂的无氯直接乙烯共聚物制成。 管或管道形式的物品具有用于医疗应用中使用的PVC基管的替代物的特殊用途。

    Methods for modulating angiogenesis
    4.
    发明授权
    Methods for modulating angiogenesis 有权
    调节血管生成的方法

    公开(公告)号:US07510714B2

    公开(公告)日:2009-03-31

    申请号:US11668663

    申请日:2007-01-30

    IPC分类号: A61K38/16 A61K38/17

    CPC分类号: A61K38/57

    摘要: Recombinant plasminogen activator inhibitor-1 (PAI-1) isoforms which lack the reactive center loop and contain the complete heparin-binding domain or lack at least a portion of the heparin-binding domain are described. The rPAI-1 isoforms disclosed herein may be used to modulate angiogenesis through blocking release of VEGF from a VEGF-heparin complex. Furthermore, the rPAI-1 proteins may be used to inhibit cell proliferation and migration, induce apoptosis, and produce proteolytic fragments corresponding to angiostatin kringles 1-3 and kringles 1-4. A truncated proteolytic plasmin protein of 34 kDa is also provided.

    摘要翻译: 描述了缺乏反应中心环并含有完整的肝素结合结构域或缺乏至少一部分肝素结合结构域的重组纤溶酶原激活物抑制剂-1(PAI-1)异构体。 本文公开的rPAI-1同种型可用于通过从VEGF-肝素复合物阻断VEGF的释放来调节血管生成。 此外,rPAI-1蛋白可用于抑制细胞增殖和迁移,诱导细胞凋亡,并产生对应于血管抑素三酮1-3和三环1-4的蛋白水解片段。 还提供了34kDa的截短的蛋白水解纤溶酶蛋白。

    Methods for modulating angiogenesis via VEGF
    5.
    发明授权
    Methods for modulating angiogenesis via VEGF 有权
    通过VEGF调节血管生成的方法

    公开(公告)号:US07241446B2

    公开(公告)日:2007-07-10

    申请号:US10506225

    申请日:2003-04-01

    IPC分类号: A61K39/00 A61K38/16 A61K38/17

    CPC分类号: A61K38/57

    摘要: Recombinant plasminogen activator inhibitor-1 (PAI-1) isoforms which lack the reactive center loop and contain the complete heparin-binding domain or lack at least a portion of the heparin-binding domain are described. The rPAI-1 isoforms disclosed herein may be used to modulate angiogenesis through blocking release of VEGF from a VEGF-heparin complex. Furthermore the rPAI-1 proteins may be used to inhibit cell proliferation and migration, induce apoptosis, and produce proteolytic fragments corresponding to angiostatin kringles 1–3 and kringles 1–4.

    摘要翻译: 描述了缺乏反应中心环并含有完整的肝素结合结构域或缺乏至少一部分肝素结合结构域的重组纤溶酶原激活物抑制剂-1(PAI-1)异构体。 本文公开的rPAI-1同种型可用于通过从VEGF-肝素复合物阻断VEGF的释放来调节血管生成。 此外,rPAI-1蛋白可用于抑制细胞增殖和迁移,诱导细胞凋亡,并产生对应于血管抑素三酮1-3和三酮酮1-4的蛋白水解片段。